JOSHUA CUTSHALL: Open Payments
NPI 1487996153 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,453 in 64 payments from 17 companies in 2025. Trend: 2023 $36 · 2024 $30 · 2025 $1,453
Food & beverage: $1,268Education: $185
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $233 |
| Regeneron Healthcare Solutions, Inc. | 11 | $190 |
| Amgen Inc. | 4 | $169 |
| Janssen Biotech, Inc. | 3 | $118 |
| UCB, Inc. | 4 | $109 |
| Galderma Laboratories, L.P. | 5 | $109 |
| GENZYME CORPORATION | 3 | $102 |
| ABBVIE INC. | 4 | $78 |
| Organon LLC | 3 | $61 |
| Lilly USA, LLC | 3 | $54 |
Products named: DUPIXENT, OTEZLA, TREMFYA, Bimzelx, NEMLUVIO, ILUMYA, LIBTAYO, Leqselvi.
Industry payments across GA — which companies pay providers there.
